ZOLMITRIPTAN - zolmitriptan tablet, film coated 
ZOLMITRIPTAN - zolmitriptan tablet, orally disintegrating United States - English - NLM (National Library of Medicine)

zolmitriptan - zolmitriptan tablet, film coated zolmitriptan - zolmitriptan tablet, orally disintegrating

macleods pharmaceuticals limited - zolmitriptan (unii: 2fs66th3yw) (zolmitriptan - unii:2fs66th3yw) - zolmitriptan 2.5 mg - zolmitriptan is indicated for the acute treatment of migraine with or without aura in adults. limitations of use - only use zolmitriptan if a clear diagnosis of migraine has been established. if a patient has no response to zolmitriptan treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan are administered to treat any subsequent attacks. - zolmitriptan is not indicated for the prevention of migraine attacks.  - safety and effectiveness of zolmitriptan have not been established for cluster headache. zolmitriptan is contraindicated in patients with: - ischemic coronary artery disease (angina pectoris, history of myocardial infarction, or documented silent ischemia), other significant underlying cardiovascular disease, or coronary artery vasospasm including prinzmetal's angina [see warnings and precautions (5.1) ]. - wolff-parkinson-white syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorders [see warnings and precautions (

Principelle MelMax wound dressing Singapore - English - HSA (Health Sciences Authority)

principelle melmax wound dressing

intega pte ltd - general hospital - melmax® can be used for the treatment of acute and chronic wounds. acute wounds, includes burns, surgical wounds, traumatic wounds, other acute wounds where fast epithelialisation is required. chronic wounds, includes leg ulcers, diabetic ulcers, decubitus ulcers, in conjunction with corticosteroid use.

RELPAX Tablets 20mg (レルパックス錠20mg) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

relpax tablets 20mg (レルパックス錠20mg)

viatris pharmaceuticals inc. - eletriptan hydrobromide - orange tablet, diameter: 6.3 mm, thickness: 3.0 mm

IPTAM MIGRAINE RELIEF sumatriptan 50 mg (as succinate) tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

iptam migraine relief sumatriptan 50 mg (as succinate) tablet blister pack

alphapharm pty ltd - sumatriptan succinate, quantity: 70 mg (equivalent: sumatriptan, qty 50 mg) - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; titanium dioxide; hypromellose; macrogol 8000; triacetin; iron oxide yellow; iron oxide red; polydextrose - for the acute relief of migraine in patients who have a stable, well-established pattern of symptoms.